Rever3mAb

N/A

Report date: 2025/03/19 11:44:29

Base Information

Drug NameRever3mAb
Drug Alias Nameanti-HER3 antibody (Takis Biotech)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonists
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsLung NeoplasmsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakis Biotech
China Registration ClassN/A

Develop Information

Active CompaniesTakis Biotech
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsMelanoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A